ResourcePath combines research and development expertise with a CLIA-licensed and College of American Pathologists-accredited, high complexity laboratory to address urgent diagnostic needs in cancer and emerging infectious diseases.

We also provide pathology and genomic services on a contract basis to universities, companies and government investigators.

 

Clinical Services and Clinical Trial Support

  • SARS-CoV-2 RT-qPCR viral testing (New )
  • DICER1 sequencing in support of the International PPB and Ovarian and Testicular Stromal Tumor Registries
  • Liquid biopsy for DICER1 cancers and H3K27M diffuse midline glioma
  • Cancer genotyping assay detecting mutations, gene amplifications and gene fusions in 161 cancer genes

Core Lab Technical Services

  • Slide staining
  • Digital slide scanning
  • RNA-seq gene expression and analysis

Consulting Services

  • Converting research assays to CAP/CLIA testing environment
  • Consulting on medical device and new diagnostic assay development
  • Pathologist review and classification of disease pre- and post-treatment
  • Pathologist tumor model evaluation
  • FDA approval application support
  • Experimental design consulting
  • Grant and manuscript support and content editing
  • Figure legend preparation

 

Operating Hours

Monday-Friday: 8:30am – 5:00pm

Saturday: 9:00am – 1:00pm

Sunday: CLOSED

 

Contact us for more information.